Schonfeld Strategic Advisors LLC Caribou Biosciences, Inc. Call Options Transaction History
Schonfeld Strategic Advisors LLC
- $15 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CRBU
# of Institutions
135Shares Held
47MCall Options Held
17.1KPut Options Held
58.1K-
Black Rock Inc. New York, NY6.95MShares$5.98 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.52MShares$3.89 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.27MShares$2.81 Million0.25% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA2.51MShares$2.16 Million0.18% of portfolio
-
Geode Capital Management, LLC Boston, MA2.05MShares$1.77 Million0.0% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $52.3M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...